NeoPharm Co Ltd:企業の戦略・SWOT・財務分析

◆英語タイトル:NeoPharm Co Ltd - Strategy, SWOT and Corporate Finance Report
◆商品コード:MLINE7094749
◆発行会社(調査会社):MarketLine
◆発行日:2017年2月28日
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆産業分野:消費財
◆販売価格オプション(消費税別)
Single UserUSD175 ⇒換算¥19,250見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD350 ⇒換算¥38,500見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD525 ⇒換算¥57,750見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000を加算
※納期:即日~2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

NeoPharm Co Ltd – Strategy, SWOT and Corporate Finance Report
Summary

NeoPharm Co Ltd – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

NeoPharm Co Ltd. (NeoPharm) is a manufacturer of skin care products. The company’s product portfolio includes anti-aging cosmeceuticals and foam wash, shampoo, soap, sun block, soothing creams, soothing lotions, foaming cleansers, shampoo, soap, and sun block for atopic, dry and sensitive skin. The company’s products are marketed under Atopalm, Zeroid and Dr. Mle brands. NeoPharm also develops new medicines for treatment of cancer, skin inflammation, asthma, atopic dermatitis and Type II diabetes. Furthermore, NeoPharm’s products and technologies are exported globally. The company operates across China, Thailand, Taiwan, Indonesia, Singapore, Hong Kong, Russia, Ukraine, Germany, and the US. NeoPharm operates as a subsidiary of Aekyung Group. NeoPharm is headquartered in DaeJeon, South Korea.

Scope

- Detailed information on NeoPharm Co Ltd required for business and competitor intelligence needs.
- A study of the major internal and external factors affecting NeoPharm Co Ltd in the form of a SWOT analysis.
- An in-depth view of the business model of NeoPharm Co Ltd including a breakdown and examination of key business segments.
- Intelligence on NeoPharm Co Ltd’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors.
- News about NeoPharm Co Ltd, such as business expansion, restructuring, and contract wins.
- Large number of easy-to-grasp charts and graphs that present important data and key trends.

Reasons to buy

- Gain understanding of NeoPharm Co Ltd and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess NeoPharm Co Ltd as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on NeoPharm Co Ltd’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
NeoPharm Co Ltd: Company Overview
NeoPharm Co Ltd: Overview and Key Facts
NeoPharm Co Ltd: Overview
NeoPharm Co Ltd: Key Facts
NeoPharm Co Ltd: Key Employees
NeoPharm Co Ltd: Key Employee Biographies
NeoPharm Co Ltd: Major Products and Services
NeoPharm Co Ltd: Company History
NeoPharm Co Ltd: Locations and Subsidiaries
NeoPharm Co Ltd: Key Competitors
NeoPharm Co Ltd: Company Analysis
NeoPharm Co Ltd: Business Description
NeoPharm Co Ltd: SWOT Analysis
NeoPharm Co Ltd: SWOT Overview
NeoPharm Co Ltd: Strengths
NeoPharm Co Ltd: Weaknesses
NeoPharm Co Ltd: Opportunities
NeoPharm Co Ltd: Threats
Appendix
Contact Us
Methodology
Definitions
About MarketLine

List of Tables
Table 1: NeoPharm Co Ltd: Key Facts
Table 2: NeoPharm Co Ltd: Key Employees
Table 3: NeoPharm Co Ltd: Locations and Subsidiaries
Table 4: NeoPharm Co Ltd: Key Competitors



★調査レポート[NeoPharm Co Ltd:企業の戦略・SWOT・財務分析] (コード:MLINE7094749)販売に関する免責事項を必ずご確認ください。
★調査レポート[NeoPharm Co Ltd:企業の戦略・SWOT・財務分析]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆